NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death is a research paper published in Frontiers in Physiology (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL143067
NHLBI NIH HHS
Grant: K08 HL123551
National Institutes of Health
Grant: 1K08HL123551-01A1
Role of KLF15 in Circadian Regulation of Cardiac Ischemia
National Institutes of Health
Grant: 5R01HL143067-03
Transcriptional regulation of cardiac pathological remodeling by REV-ERBα
National Institutes of Health
FWCI
2.35
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals